已收盘 12-19 16:00:00 美东时间
-0.010
-0.08%
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
11-06 19:12
Jefferies analyst Glen Santangelo maintains Viatris (NASDAQ:VTRS) with a Buy and lowers the price target from $15 to $13.
03-08 01:17
本周一,美国股票市场迎来了特朗普政府新关税政策生效后的首个交易日,市场一度陷入恐慌性抛售,随后跌幅有所收窄。这种市场情绪可能预示着未来的波动格局,在此背景下,投...
02-04 06:00
Regeneron filed an appeal after a court's decision, which was issued under seal.
2024-09-25 02:21
CC Lagator of Options AI warns traders to expect increased volatility in the week after September's 'triple witching,' with over $5 trillion in options expiring and historical evidence of market turbulence. VIX at 16 presents attractive opportunities for call option buyers.
2024-09-20 22:51
Increase in production of Takeda's ADHD drug Vyvanse, approved by DEA to address ongoing shortages both domestically and globally.
2024-09-06 21:46
06:38 AM EDT, 09/04/2024 (MT Newswires) -- Viatris (VTRS) said Wednesday that the company and its units, Mylan and Utah Acquisition Sub, have launched cash tender offers to purchase all the outstanding $750 million of 1.65% senior notes due 2025 and 500 million euros ($552.7 million) of 2.125% senio...
2024-09-04 18:38
The ACT-333441 study was accepted as a late-breaking abstract and was presented during an oral presentation at the 26th Asia-Pacific League of Associations for Rheumatology (APLAR) Annual Congress. The congress is being held August 21-25, 2024, in Suntec, Singapore.
2024-08-23 19:00